mark. back up plan
- Manufacturer
- Avon Products, Inc.
- Effective date
- 2009-12-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:24:54
Label at a glance#
Productmark. back up plan Anti-Acne Back Treatment
Active ingredientSalicylic Acid
Label structure7 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active/Medicinal ingredient Purpose
Salicylic Acid 2.0%..................Acne Treatment
INDICATIONS & USAGE SECTION
Uses
• helps in the treatment of acne
• helps clear up acne blemishes
• helps prevent new acne blemishes
from forming
• penetrates pores to eliminate most
blackheads and acne pimples
WARNINGS SECTION
Warnings
For external use only
OTC - WHEN USING SECTION
When using this product
• avoid contact with eyes. If product
contacts eyes, rinse thoroughly with water.
• if excessive skin irritation develops or
increases, discontinue use. If irritation
persists, consult a health care practitioner.
• using other topical acne products at the
same time or immediately following use of
this product may increase dryness or
irritation of the skin. If this occurs, only one
product should be used unless directed by
a health care practitioner
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed,
get medical help or contact a Poison Control
Center right away.
STORAGE AND HANDLING SECTION
Flammable. Keep away from heat or flame.
DOSAGE & ADMINISTRATION SECTION
Directions
• cleanse skin thoroughly with non-medicated
cleanser before applying medication
• apply to blemish-prone areas one to
three times daily or as directed by a
health care practitioner
• because excessive drying of the skin
may occur, start with one application daily,
then gradually increase to two to three times
daily if needed or as directed by a
health care practitioner
• if bothersome dryness or peeling occurs,
reduce application to once a day or
every other day
INACTIVE INGREDIENT SECTION
Inactive/Non-medicinal ingredients:
Water/Eau, SD Alcohol 40-B, Hamamelis
Virginiana (Witch Hazel) Extract, Pyrus Malus
(Apple) Fruit Extract, Cinnamomum Cassia
Bark Extract, Trideceth-9, Potassium
Hydroxide, Citric Acid, Disodium EDTA,
Pyridoxine HCL.
OTC - QUESTIONS SECTION
Questions? Call 1-800-FOR-AVON or
1-800-265-AVON in Canada
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10096-0192-2 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d0b6-621f-e053-dbdaa90a74ad | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10096-0192-1 | mark. back up planAnti-Acne Back Treatment | 118 mL in 1 BOTTLE, SPRAY | SPRAY | 118 | 1 | |
| 10096-0192-2 | mark. back up planAnti-Acne Back Treatment | 1 in 1 CARTON | SPRAY | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10096-0192 | MARK. BACK UP PLAN ANTI-ACNE BACK TREATMENT (SALICYLIC ACID) SPRAY [AVON PRODUCTS, INC.] | 1 | Legacy NDC, 2 package rows | 20100625_5e58ed4b-0044-41d7-80e1-ffc207a16c4f.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 1 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- mark. back up plan Anti-Acne Back Treatment
- Salicylic Acid
- WATER
- POTASSIUM HYDROXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10096-0192 | 10096-0192-1, 10096-0192-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Salicylic Acid | O414PZ4LPZ | ACTIB |
| WATER | 059QF0KO0R | IACT |
| POTASSIUM HYDROXIDE | WZH3C48M4T | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / INTRAVASCULAR | NA | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, DELAYED RELEASE / ORAL | 5 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / VAGINAL | 3 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | INJECTION / INTRAVENOUS | ADJ PH | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / ORAL | ADJ PH | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, LIQUID FILLED / ORAL | 154 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE / ORAL | 172 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | PASTILLE / ORAL | ADJ PH | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3c8a938b-ce64-4fd7-a955-be6ca9ab0731 | 5e58ed4b-0044-41d7-80e1-ffc207a16c4f | 2009-12-29 | Warnings | 3c8a938b-ce64-4fd7-a955-be6ca9ab0731 5e58ed4b-0044-41d7-80e1-ffc207a16c4f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.